Literature DB >> 7239799

Vitamin utilization status in chronic alcoholics.

S K Majumdar, G K Shaw, A D Thomson.   

Abstract

Chronic alcoholics are very often found to be deficient in vitamins. The object of the study was to assess the vitamin utilization of twelve drinking chronic alcoholics after intravenous therapy with polyvitamins. The following enzyme activation tests in red blood cells were used: a) Erythrocyte transketolase (ETK) activity for B1; b) Glutathione reductase (EGR) activity for B2; c) Pyridoxal-5-phosphate (PALP)--the active metabolite of vitamin B6 (pyridoxine) was directly estimated in red blood cells. Seven out of 12 patients were deficient in B1 before treatment; 6/12 in B2 and 11/12 in PALP. But all returned to normal after treatment; mean plus or minus SD of ETK activation co-efficient improved from the pre-treatment level of 1.174 plus or minus 0.135 to 1.001 plus or minus 0.009 (adequate less than or equal to 1.15); mean plus or minus SD of EGR activation coefficient from 1.265 plus or minus 0.333 to 1.015 plus or minus 0.072 (adequate less than or equal to 1.19) and PALP rose from 6.78 plus or minus 6.47 to 60.68 plus or minus 85.85 after treatment (adequate = vv10-20 ng/ml). These observations indicate the need for relevant vitamin supplementation in chronic alcoholics and also support the inclusion of intravenous polyvitamins in conventional detoxification regime for chronic alcoholics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239799

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  11 in total

1.  Chronic alcohol feeding inhibits physiological and molecular parameters of intestinal and renal riboflavin transport.

Authors:  Veedamali S Subramanian; Sandeep B Subramanya; Abhisek Ghosal; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

2.  Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.

Authors:  Ram Lakhan; Veedamali S Subramanian; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-14       Impact factor: 4.052

3.  Neuro-toxic interaction in alcohol-treated, thiamine-deficient mice.

Authors:  S C Phillips
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Adult zebrafish as an in vivo drug testing model for ethanol induced acute hepatic injury.

Authors:  Ki-Hoon Park; Seok-Hyung Kim
Journal:  Biomed Pharmacother       Date:  2020-10-06       Impact factor: 6.529

5.  Mechanisms underlying the differential effects of ethanol on the bioavailability of riboflavin and flavin adenine dinucleotide.

Authors:  J Pinto; Y P Huang; R S Rivlin
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Blood-brain barrier dysfunction in thiamine-deficient, alcohol-treated rats.

Authors:  S C Phillips; B G Cragg
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

7.  Mechanism and regulation of vitamin B2 (riboflavin) uptake by mouse and human pancreatic β-cells/islets: physiological and molecular aspects.

Authors:  Abhisek Ghosal; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-23       Impact factor: 4.052

8.  The influence of vitamin B6 deficiency on somatosensory stimulus conduction in the rat.

Authors:  D Claus; B Neundörfer; K Warecka
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

9.  Identification and characterization of 5'-flanking region of the human riboflavin transporter 1 gene (SLC52A1).

Authors:  Subrata Sabui; Abhisek Ghosal; Hamid M Said
Journal:  Gene       Date:  2014-10-05       Impact factor: 3.688

10.  Flavin Adenine Dinucleotide Depletion Caused by electron transfer flavoprotein subunit alpha Haploinsufficiency Leads to Hepatic Steatosis and Injury in Zebrafish.

Authors:  Ki-Hoon Park; Monika Gooz; Zhi-Wei Ye; Jie Zhang; Gyda C Beeson; Don C Rockey; Seok-Hyung Kim
Journal:  Hepatol Commun       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.